Full Fed. Circ. Won't Review Inventorship Row Over Cancer IP

By Britain Eakin · October 16, 2020, 6:13 PM EDT

The full Federal Circuit Friday rejected a bid from Bristol-Meyers and others for review of a panel decision that two American scientists from the Dana-Farber Cancer Institute should be named as...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Dana-Farber Cancer Institute v. Ono Pharmaceutical Co., Ltd.

Case Number

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Question)

Date Filed

June 19, 2019

Recent Articles By Britain

October 30, 2024
Access To 'Dreamer' Info Limited In Suit Over HHS Rule
August 22, 2024
2nd Circ. Says Feds Can't Forcibly Drug Man Facing Removal
August 14, 2024
GSA Hit With Protest Over $985M Migrant Kid Transport Deal
June 27, 2024
Ga. Judge Says NBC Falsely Reported Mass Hysterectomies
May 30, 2024
Full 9th Circ. Won't Rehear Immigration Attys' Privacy Row
January 31, 2024
Final Immigration Fee Hikes Seen As 'Tax' On Employers
December 08, 2023
How Immigration Can Fill Labor Gaps — A Series
December 01, 2023
Special Visas Needed To Address Health Labor Shortages
November 30, 2023
DOL Board Says Labor Shortage Can't Justify H-2B Caregivers
September 19, 2023
IT Firm Says NJ Court Can't Hear Ex-Exec's Termination Suit